Your browser doesn't support javascript.
loading
Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients.
Zhao, Yan; Li, Hailiang; Bai, Wei; Liu, Jueshi; Lv, Weifu; Sahu, Sonia; Guan, Sheng; Qin, Xiao; Wang, Wenhui; Ren, Weixin; Mu, Wei; Guo, Weidong; Gu, Shanzhi; Ma, Yilong; Yin, Zhanxin; Guo, Wengang; Wang, Wenjun; Wang, Yongji; Duran, Rafael; Fan, Daiming; Zhang, Zhuoli; Han, Guohong.
Afiliação
  • Zhao Y; Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Li H; Department of Interventional Radiology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Bai W; Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Liu J; Department of Interventional Radiology and Vascular Surgery, Hunan Provincial People's Hospital, Changsha, China.
  • Lv W; Department of Radiology, Anhui Provincial Hospital, Hefei, China.
  • Sahu S; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston.
  • Guan S; Second Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Qin X; Department of Hepatobiliary Surgery & Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Wang W; Department of Interventional Medicine, The First Affiliated Hospital of Lanzhou University, Lanzhou, China.
  • Ren W; Department of Interventional Radiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
  • Mu W; Department of Radiology, The Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Guo W; Cancer Treatment Center, Baogang Hospital of Inner Mongolia, Baotou, China.
  • Gu S; Department of Interventional Radiology, Hunan Cancer Hospital of Central South University, Changsha, China.
  • Ma Y; Department of Interventional Therapy, Tumor Hospital of Guangxi Medical University, Nanning, China.
  • Yin Z; Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Guo W; Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Wang W; Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Wang Y; Department of Medical Statistics, Fourth Military Medical University, Xi'an, China.
  • Duran R; Department of Radiology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Fan D; Department of Liver Disease and Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Zhang Z; State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
  • Han G; Department of Radiology, Northwestern University, Chicago.
Int J Cancer ; 139(4): 928-37, 2016 Aug 15.
Article em En | MEDLINE | ID: mdl-27038145
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quimioembolização Terapêutica / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quimioembolização Terapêutica / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China